The Medicines Company
The Medicines Company Acquires CU-2010 and Curacyte Discovery GmbH
Published in Blood Weekly, August 21st, 2008
CU-2010 is a small molecule serine protease inhibitor. In preclinical studies, the compound has demonstrated a favorable pharmacokinetic profile for the surgical setting with a rapid onset and offset of effect, due to its short half life. The molecule was designed and is being developed to address a significant unmet medical need that has intensified for clinicians since the recent withdrawal of aprotinin. The Medicines Company expects to commence Phase I clinical...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-08-21)
More Articles from Blood Weekly
- Acute Pancreatitis
Research from Shanghai Jiao Tong University in the area of acute pancreatitis published - Acute Pancreatitis
Studies from T. Decampos et al in the area of acute pancreatitis described - Acute Promyelocytic Leukemia
Studies conducted at S.J. Collins et al on acute promyelocytic leukemia recently published - Adverse Drug Reactions
Research on adverse drug reactions described by M.G. Orgeas and colleagues - Cardiology
New cardiology study findings recently were reported by researchers at University of British Columbia - Chronic Myelogenous Leukemia
Recent findings in chronic myelogenous leukemia described by researchers from Cleveland Clinic - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
